Atlanta, GA - Rate control is at least as good as rhythm control for patients with persistent atrial fibrillation, according to two late-breaking sessions presented here at the American College of ...

A strategy of early rhythm control for atrial fibrillation (AF), compared with a rate-control approach, led to a reduction in risk for a composite cardiovascular (CV) endpoint over 5 years, whether ...

Boston Scientific ($BSX) announced an update on their ongoing clinical study. Study OverviewThis global Boston Scientific trial, officially titled ...

Maintenance of sinus rhythm is the main therapeutic goal in patients with atrial fibrillation. However, recurrences of atrial fibrillation and side effects of antiarrhythmic drugs offset the benefits ...

Advancements in research and technology are leading to treatments that transform the lives of people affected by the most common supraventricular heart arrhythmia, atrial fibrillation (AFib). Today ...

In December 2023, Boston Scientific Corporation (NYSE: BSX) initiated the AVANT GUARD trial to evaluate the safety and effectiveness of the FARAPULSE Pulsed Field Ablation (PFA) System as a first-line ...

Please provide your email address to receive an email when new articles are posted on . SAN FRANCISCO — A novel mapping system to identify drivers of atrial fibrillation beyond the pulmonary vein was ...

A common stomach bug may also be linked to the development of irregular heart rhythm, also known as atrial fibrillation, suggests a small study in Heart. A common stomach bug may also be linked to the ...

Recurrent arrhythmia, where irregular heart rhythms return even after treatment, can present challenges and increase the risk of complications, but can be managed with a cardiologist’s help and ...

Using a 3-D motion-detection system, researchers measured whether baseball pitchers were at risk for shoulder injuries, according to a recent study published in Musculoskeletal Surgery. Tonino and ...